KORU MEDICAL SYSTEMS INC (KRMD) Stock Price & Overview

NASDAQ:KRMDUS7599101026

Current stock price

4.21 USD
-0.09 (-2.09%)
At close:
4.21 USD
0 (0%)
After Hours:

The current stock price of KRMD is 4.21 USD. Today KRMD is down by -2.09%. In the past month the price decreased by -11.18%. In the past year, price increased by 49.82%.

KRMD Key Statistics

52-Week Range1.86 - 6.608
Current KRMD stock price positioned within its 52-week range.
1-Month Range4.1 - 5.12
Current KRMD stock price positioned within its 1-month range.
Market Cap
195.218M
P/E
N/A
Fwd P/E
275.16
EPS (TTM)
-0.05
Dividend Yield
N/A

KRMD Stock Performance

Today
-2.09%
1 Week
-1.64%
1 Month
-11.18%
3 Months
-27.41%
Longer-term
6 Months +1.20%
1 Year +49.82%
2 Years +78.39%
3 Years -0.24%
5 Years +19.60%
10 Years N/A

KRMD Stock Chart

KORU MEDICAL SYSTEMS INC / KRMD Daily stock chart

KRMD Technical Analysis

ChartMill assigns a technical rating of 2 / 10 to KRMD. When comparing the yearly performance of all stocks, KRMD is one of the better performing stocks in the market, outperforming 76.85% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

KRMD Fundamental Analysis

ChartMill assigns a fundamental rating of 3 / 10 to KRMD. While KRMD seems to be doing ok healthwise, there are quite some concerns on its profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

KRMD Earnings

On March 12, 2026 KRMD reported an EPS of -0.01 and a revenue of 10.90M. The company beat EPS expectations (50.49% surprise) and missed revenue expectations (-1.29% surprise).

Next Earnings DateMay 11, 2026
Last Earnings DateMar 12, 2026
PeriodQ4 / 2025
EPS Reported-$0.01
Revenue Reported10.895M
EPS Surprise 50.49%
Revenue Surprise -1.29%

KRMD Forecast & Estimates

11 analysts have analysed KRMD and the average price target is 6.73 USD. This implies a price increase of 59.9% is expected in the next year compared to the current price of 4.21.

For the next year, analysts expect an EPS growth of 66.85% and a revenue growth 22.02% for KRMD


Analysts
Analysts80
Price Target6.73 (59.86%)
EPS Next Y66.85%
Revenue Next Year22.02%

KRMD Groups

Sector & Classification

KRMD Financial Highlights

Over the last trailing twelve months KRMD reported a non-GAAP Earnings per Share(EPS) of -0.05. The EPS increased by 50% compared to the year before.


Income Statements
Revenue(TTM)41.13M
Net Income(TTM)-2.64M
Industry RankSector Rank
PM (TTM) N/A
ROA -9.35%
ROE -15.47%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%66.67%
Sales Q2Q%23.26%
EPS 1Y (TTM)50%
Revenue 1Y (TTM)22.23%

KRMD Ownership

Ownership
Inst Owners56.79%
Shares46.37M
Float42.11M
Ins Owners9.2%
Short Float %1.71%
Short Ratio3.6

About KRMD

Company Profile

KRMD logo image KORU Medical Systems, Inc. engages in the design, manufacture, and market of proprietary medical devices. The company is headquartered in Mahwah, New Jersey and currently employs 73 full-time employees. The firm is focused on developing, manufacturing, and commercializing patient-centric large volume subcutaneous infusion solutions primarily for the subcutaneous drug delivery market. The firm is focused on its mechanical infusion products, the FREEDOM Infusion Systems (FREEDOM System), which include the FREEDOM60 Syringe Driver, the FreedomEdge Syringe Driver, HIgH-Flo Subcutaneous Safety Needle Sets and Precision Flow Rate Tubing. The Company’s infusion devices work together as a system to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases (PIDD) and chronic inflammatory demyelinating polyneuropathy (CIDP). The FREEDOM System operates at a lower pressure than an electrical, volumetric pump and maintains a balance between what a patient’s subcutaneous tissues can tolerate and what the system delivers.

Company Info

IPO: 1993-10-27

KORU MEDICAL SYSTEMS INC

100 Corporate Drive

Mahwah NEW JERSEY 10918 US

CEO: James M. Beck

Employees: 73

KRMD Company Website

KRMD Investor Relations

Phone: 18454692042

KORU MEDICAL SYSTEMS INC / KRMD FAQ

What does KRMD do?

KORU Medical Systems, Inc. engages in the design, manufacture, and market of proprietary medical devices. The company is headquartered in Mahwah, New Jersey and currently employs 73 full-time employees. The firm is focused on developing, manufacturing, and commercializing patient-centric large volume subcutaneous infusion solutions primarily for the subcutaneous drug delivery market. The firm is focused on its mechanical infusion products, the FREEDOM Infusion Systems (FREEDOM System), which include the FREEDOM60 Syringe Driver, the FreedomEdge Syringe Driver, HIgH-Flo Subcutaneous Safety Needle Sets and Precision Flow Rate Tubing. The Company’s infusion devices work together as a system to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases (PIDD) and chronic inflammatory demyelinating polyneuropathy (CIDP). The FREEDOM System operates at a lower pressure than an electrical, volumetric pump and maintains a balance between what a patient’s subcutaneous tissues can tolerate and what the system delivers.


What is the current price of KRMD stock?

The current stock price of KRMD is 4.21 USD. The price decreased by -2.09% in the last trading session.


What is the dividend status of KORU MEDICAL SYSTEMS INC?

KRMD does not pay a dividend.


What is the ChartMill technical and fundamental rating of KRMD stock?

KRMD has a ChartMill Technical rating of 2 out of 10 and a ChartMill Fundamental rating of 3 out of 10.


Where is KORU MEDICAL SYSTEMS INC (KRMD) stock traded?

KRMD stock is listed on the Nasdaq exchange.


Should I buy KRMD stock?

This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on KRMD.